Biodexa Pharmaceuticals Plc BDRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • GB • USD

SharesGrow Score

27/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Stock Statistics — BDRX

Biodexa Pharmaceuticals Plc (BDRX) has a market capitalization of $545.21K and trades at $3.25. The 52-week range is 0.8008-96.5.

The stock has a beta of 1.11, operates in the Healthcare sector.

Trading Data

Current Price$3.25

52-Week Range0.8008-96.5

Volume57.07K

Avg Volume (30D)481.96K

Market Cap$545.21K

Beta (1Y)1.11

Company

IPO Date2015-12-07

Employees13

CEOStephen Anthony Stamp

CountryGB

ExchangeNASDAQ Capital Marke

CurrencyUSD

ISINUS59564R8806

CUSIP59564R880

Income (Latest Year)

Gross Profit$-184.86K

EBITDA$-8.08M

Operating Income$-8.27M

Net Income$-6.24M

Shares Outstanding$548.61M

Balance Sheet (Latest Year)

Total Assets$18.15M

Current Assets$12.42M

Cash & ST Investments$8.52M

Total Liabilities$6.76M

Total Debt$60.89K

Net Debt$-8.46M

Total Equity$11.38M

Debt / Equity0.01

Valuation Ratios

P/B Ratio0.05

People Also View

ESLA

Estrella Immunopharma, Inc.

$1.73

-1.14%

KZIA

Kazia Therapeutics Limited

Galmed Pharmaceuticals Ltd.

Can-Fite BioPharma Ltd.

$3.05

+4.45%

CNSP

CNS Pharmaceuticals, Inc.

$2.64

+5.18%

INM

InMed Pharmaceuticals Inc.

$0.71

+0.29%

Biodexa Pharmaceuticals Plc BDRX NASDAQ

Stock Statistics — BDRX

People Also View

Get Undervalued Stock Alerts